Non-coding RNAs in cardiac remodeling and heart failure.
about
MicroRNAs in Valvular Heart Diseases: Potential Role as Markers and Actors of Valvular and Cardiac RemodelingPotential of non-coding RNA as biomarkers in heart failureSmall molecules, big effects: the role of microRNAs in regulation of cardiomyocyte deathCalcium dysregulation in atrial fibrillation: the role of CaMKIIFacts and updates about cardiovascular non-coding RNAs in heart failureMicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena?MicroRNAs in cardiovascular disease: an introduction for cliniciansRecent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic DrugsmiR-206 Mediates YAP-Induced Cardiac Hypertrophy and SurvivalRole of circulating factors in cardiac aging.Heart Failure in Pediatric Patients With Congenital Heart Disease.Myocardial fibrosis: biomedical research from bench to bedside.Intense light-elicited upregulation of miR-21 facilitates glycolysis and cardioprotection through Per2-dependent mechanisms.MicroRNAs in right ventricular (dys)function (2013 Grover Conference series).Phenotypic characterization of miR-92a-/- mice reveals an important function of miR-92a in skeletal development.Heart failure with preserved ejection fraction: molecular pathways of the aging myocardiumAnalysis of circulating microRNAs in patients with repaired Tetralogy of Fallot with and without heart failure.Circulating level of miR-378 predicts left ventricular hypertrophy in patients with aortic stenosisCirculating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device.Inhibition of Let-7 microRNA attenuates myocardial remodeling and improves cardiac function postinfarction in mice.Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs.Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.MicroRNA profiling of pericardial fluid samples from patients with heart failureRight ventricular long noncoding RNA expression in human heart failureMicroRNA signatures differentiate preserved from reduced ejection fraction heart failureHeart Failure in Chronic Myocarditis: A Role for microRNAs?FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy.MicroRNA Clusters in the Adult Mouse Heart: Age-Associated Changes.Rheostatic Regulation of the SERCA/Phospholamban Membrane Protein Complex Using Non-Coding RNA and Single-Stranded DNA oligonucleotides.Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury: Role of Human CD34+ Cells Deficient in MicroRNA-377.NFAT as cancer target: mission possible?Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure OverloadReciprocal Changes of Circulating Long Non-Coding RNAs ZFAS1 and CDR1AS Predict Acute Myocardial InfarctionAtrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signalIdentification of cardiac-related circulating microRNA profile in human chronic heart failure.C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and DysfunctionBlood-based microRNA signatures differentiate various forms of cardiac hypertrophy.Crucial Role of miR-433 in Regulating Cardiac FibrosisMicroRNA basis of physiological hypertrophy.Regulatory RNAs and paracrine networks in the heart.
P2860
Q26740102-F2F5E83F-8418-4CC0-9C86-42EF4E1358EAQ26784127-193EBB75-D1A2-4CD2-8A0A-2BA4AC2468E7Q26995349-AFEA4162-74F9-413C-9E52-98E90AFAC7F4Q27027326-F8A9679A-CAEB-47BB-9986-83B69A394F5DQ28072307-2054C9E9-9F33-4BB2-A018-30F812336909Q28076541-F4E1B1CB-451D-4271-AEB3-F03903E09726Q28084229-EB0A4E22-8804-4A4B-B1BB-8E68A91D4D19Q28087776-06B9A485-B0D0-4CE6-8872-2CE8896597D7Q28579456-8CA6F4C3-EE32-4D08-96EF-45E4F25DA2AEQ30234641-46B51633-B9A8-4EE0-97D4-897578C11315Q30235239-3215D585-89A4-4435-98E1-3F843941D3D0Q30362840-1C50FDCB-66A5-4F99-8D86-EC4AA19BD07FQ33610660-A5B61838-E110-464F-B39A-58B636A473C4Q33806013-5E8E53EE-B11B-45A7-BF52-000FED28021BQ33825778-1D113F62-78FC-4A45-A22B-5E480D0490E4Q33889242-09D95E0E-1BF9-49DD-9ECB-5477C747C9BFQ33892136-62CEEDE5-3966-4A8B-8755-529C529CDB94Q34089884-9ECF1432-2C78-4A3A-AEC0-E1760650FC65Q34093561-333ECE32-484A-416A-A238-7A1A0F6AF7CDQ34292584-E8BFFCD1-B6B4-45EE-9279-BAC6E1E5823DQ35059513-B1E14D0B-3BD8-44E4-8DAB-51E740FEF6B5Q35108974-F466B130-C443-4457-8F28-EE15BA983371Q35170871-EFFF1FF3-68E8-4A81-B998-E9F4E56148B1Q35517383-76B300F3-98CB-4A16-ABE0-4DDC6586243AQ35565357-2E7C25DC-DC97-498C-ACEF-6E278316E77FQ35742151-401EB3E1-982A-4FAB-8C88-A215CDF1177AQ35772405-E2DC87D6-99F6-4218-A9F7-146C2950D1F5Q35843166-2C1502E9-B1BB-43DA-ADE9-2661B48D9645Q35979145-8A2B36AD-1F3B-4854-AEDB-5A1A5A4DF7D9Q36278997-A721344A-3292-402C-9BCA-79F199EC185AQ36455193-F2093320-2FAE-4122-9422-581A27877D51Q36634367-DA6EAE49-EE47-4194-8607-562A9A16D62DQ36635649-28753FFA-5F12-43CD-8D25-B8C6D7C7D15CQ36650585-7E413130-C754-42CF-AD59-50AA1EAD8629Q36729339-7E0CD36D-C3AB-4B53-AA16-1B14FEE8F1A6Q36956778-E363785F-1E16-4528-AD6C-3BED81984206Q37074084-F71D09F7-7667-4BDB-B718-481CA788812EQ37291267-EB2B0C5B-866F-4A2A-BB93-D6E9DB6F665AQ37342263-F2D51E91-F6DD-4701-B524-7E031506BD06Q38190443-80921752-673F-4DC0-8273-F15175A98484
P2860
Non-coding RNAs in cardiac remodeling and heart failure.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Non-coding RNAs in cardiac remodeling and heart failure.
@en
type
label
Non-coding RNAs in cardiac remodeling and heart failure.
@en
prefLabel
Non-coding RNAs in cardiac remodeling and heart failure.
@en
P1433
P1476
Non-coding RNAs in cardiac remodeling and heart failure
@en
P2093
Regalla Kumarswamy
P304
P356
10.1161/CIRCRESAHA.113.300226
P50
P577
2013-08-01T00:00:00Z